Biosynex Extends Tender Offer for the shares of ChembioEURONEXT
Biosynex Extends Tender Offer for the shares of Chembio Diagnostics, Inc.
BUY AT 9.83
SL 5.78
−3.574 EUR
−36.95 M EUR
92.98 M EUR
4.67 M
About BIOSYNEX
Sector
Industry
CEO
Larry Abensur
Website
Headquarters
Illkirch-Graffenstaden
Founded
2005
ISIN
FR0011005933
FIGI
BBG001K1B795
Biosynex SA engages in the provision of development, production, and distribution of Rapid Diagnostics Tests (RDTs) for pathologies. It operates through the Professional and Consumer segments. The Professional segment allows proper medical management of the patients. The Consumer segment permits the general public to self-monitor. The company was founded by Larry Abensur, Thomas Lamy, and Thierry Paper on March 15, 2005 and is headquartered in Illkirch-Graffenstaden, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALBIO is 1.296 EUR — it has decreased by −4.00% in the past 24 hours. Watch BIOSYNEX stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange BIOSYNEX stocks are traded under the ticker ALBIO.
ALBIO stock has fallen by −25.09% compared to the previous week, the month change is a −54.69% fall, over the last year BIOSYNEX has showed a −84.04% decrease.
ALBIO reached its all-time high on Apr 15, 2021 with the price of 30.380 EUR, and its all-time low was 1.516 EUR and was reached on Dec 6, 2024. View more price dynamics on ALBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALBIO stock is 4.65% volatile and has beta coefficient of 0.36. Track BIOSYNEX stock price on the chart and check out the list of the most volatile stocks — is BIOSYNEX there?
Today BIOSYNEX has the market capitalization of 13.95 M, it has decreased by −3.01% over the last week.
Yes, you can track BIOSYNEX financials in yearly and quarterly reports right on TradingView.
ALBIO net income for the last half-year is −21.00 M EUR, while the previous report showed −17.55 M EUR of net income which accounts for −19.64% change. Track more BIOSYNEX financial stats to get the full picture.
As of Dec 22, 2024, the company has 575.00 employees. See our rating of the largest employees — is BIOSYNEX on this list?
Like other stocks, ALBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOSYNEX stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOSYNEX technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOSYNEX stock shows the strong sell signal. See more of BIOSYNEX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.